FDMTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
4D Molecular Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$12.29+0.15 (+1.24%)
Close on Oct 19, 2026
- Market cap
- $863.64M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of 4D Molecular Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 18, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 18, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 22, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2025 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2025 | Oct 31, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Oct 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jul 2, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2025 | Apr 29, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2025 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 8, 2025 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2024 | Dec 11, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2024 | Sep 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2024 | Jul 23, 2024 | SEC EDGAR |